Showing 25 to 36 of 45 results
Highly Accurate Urine Test Shows Promise for Routine Prostate Cancer Screening
A new urine test for prostate cancer, achieving an AUC score of 0.92 compared to PSA's 0.65-0.75, is undergoing a large-scale (£42 million) UK clinical trial (250,000-300,000 men over 8 years) to assess its potential for routine screening, aiming to reduce the over 12,000 annual deaths from this can...
Highly Accurate Urine Test Shows Promise for Routine Prostate Cancer Screening
A new urine test for prostate cancer, achieving an AUC score of 0.92 compared to PSA's 0.65-0.75, is undergoing a large-scale (£42 million) UK clinical trial (250,000-300,000 men over 8 years) to assess its potential for routine screening, aiming to reduce the over 12,000 annual deaths from this can...
Progress
40% Bias Score
NHS Urges Public Vigilance for Subtle Cancer Signs
The NHS launched a campaign urging people to be vigilant for subtle changes in their bodies that could indicate cancer, highlighting the importance of early diagnosis in improving treatment outcomes; a survey revealed that fewer than 40 percent of people regularly check their bodies for warning sign...
NHS Urges Public Vigilance for Subtle Cancer Signs
The NHS launched a campaign urging people to be vigilant for subtle changes in their bodies that could indicate cancer, highlighting the importance of early diagnosis in improving treatment outcomes; a survey revealed that fewer than 40 percent of people regularly check their bodies for warning sign...
Progress
40% Bias Score
Delayed Bowel Cancer Diagnosis Highlights Systemic Healthcare Issues
Rhiannon Coombs, 34, from Victoria, Australia, was diagnosed with stage three bowel cancer after a two-year delay in diagnosis due to misdiagnosis and long waiting lists, highlighting the critical need for early detection and patient advocacy in bowel cancer treatment.
Delayed Bowel Cancer Diagnosis Highlights Systemic Healthcare Issues
Rhiannon Coombs, 34, from Victoria, Australia, was diagnosed with stage three bowel cancer after a two-year delay in diagnosis due to misdiagnosis and long waiting lists, highlighting the critical need for early detection and patient advocacy in bowel cancer treatment.
Progress
20% Bias Score
Woman Ends Cancer Treatment After Nine Years, Advocates for Earlier Screenings
A 55-year-old California woman, Jamie Comer, is ending treatment after a nine-year battle with stage four colon cancer, advocating for earlier cancer screenings after her diagnosis at 47, when the recommended screening age was 50, now lowered to 45.
Woman Ends Cancer Treatment After Nine Years, Advocates for Earlier Screenings
A 55-year-old California woman, Jamie Comer, is ending treatment after a nine-year battle with stage four colon cancer, advocating for earlier cancer screenings after her diagnosis at 47, when the recommended screening age was 50, now lowered to 45.
Progress
36% Bias Score
AI System Shows Promise for Early Dementia Detection
Each year, at least 10 million people are diagnosed with dementia worldwide, with 93% being over 65. By 2050, cases may surpass 139 million. A Cambridge University researcher discusses a new AI system for early detection and prevention strategies.
AI System Shows Promise for Early Dementia Detection
Each year, at least 10 million people are diagnosed with dementia worldwide, with 93% being over 65. By 2050, cases may surpass 139 million. A Cambridge University researcher discusses a new AI system for early detection and prevention strategies.
Progress
44% Bias Score
Blood Test Research for Early Diagnosis of Rare Womb Cancer
Researchers at the University of Leicester are developing a blood test to improve the diagnosis of uterine sarcomas, a rare womb cancer affecting 3% of womb cancer patients and often misdiagnosed as fibroids; this project, funded by The Eve Appeal and Sarcoma UK, aims to detect small fragments of tu...
Blood Test Research for Early Diagnosis of Rare Womb Cancer
Researchers at the University of Leicester are developing a blood test to improve the diagnosis of uterine sarcomas, a rare womb cancer affecting 3% of womb cancer patients and often misdiagnosed as fibroids; this project, funded by The Eve Appeal and Sarcoma UK, aims to detect small fragments of tu...
Progress
28% Bias Score
Ovarian Cancer: Suffolk Women Share Experiences, Underscoring Need for Earlier Diagnosis
Three women in Suffolk share their experiences with ovarian cancer, highlighting the often-missed early symptoms (abdominal pain, bloating, frequent urination, and rapid satiety) and emphasizing the importance of patient advocacy for timely diagnosis and treatment.
Ovarian Cancer: Suffolk Women Share Experiences, Underscoring Need for Earlier Diagnosis
Three women in Suffolk share their experiences with ovarian cancer, highlighting the often-missed early symptoms (abdominal pain, bloating, frequent urination, and rapid satiety) and emphasizing the importance of patient advocacy for timely diagnosis and treatment.
Progress
40% Bias Score
AI System Improves Gastric Biopsy Analysis for Early Cancer Detection
An AI system analyzes gastric biopsy scans to quantify precancerous changes, improving the speed and accuracy of chronic gastritis diagnosis and treatment, potentially reducing gastric cancer risk. The model is currently trained on 60 WSI images and is planned for integration into pathology systems ...
AI System Improves Gastric Biopsy Analysis for Early Cancer Detection
An AI system analyzes gastric biopsy scans to quantify precancerous changes, improving the speed and accuracy of chronic gastritis diagnosis and treatment, potentially reducing gastric cancer risk. The model is currently trained on 60 WSI images and is planned for integration into pathology systems ...
Progress
44% Bias Score
New Biomarker Predicts Alzheimer's Cognitive Decline
Researchers at Stanford University have discovered a new biomarker—a ratio of two synaptic proteins (YWHAG and NPTX2)—that accurately predicts cognitive decline in Alzheimer's disease, potentially improving early diagnosis and treatment selection.
New Biomarker Predicts Alzheimer's Cognitive Decline
Researchers at Stanford University have discovered a new biomarker—a ratio of two synaptic proteins (YWHAG and NPTX2)—that accurately predicts cognitive decline in Alzheimer's disease, potentially improving early diagnosis and treatment selection.
Progress
24% Bias Score
Early Speech Changes Indicate Alzheimer's Disease
Alzheimer's disease, a leading cognitive disorder, shows early signs in speech, including word-finding difficulties, substitutions, and task avoidance; early detection is crucial for support and treatment, especially in high-risk individuals like those with Down syndrome.
Early Speech Changes Indicate Alzheimer's Disease
Alzheimer's disease, a leading cognitive disorder, shows early signs in speech, including word-finding difficulties, substitutions, and task avoidance; early detection is crucial for support and treatment, especially in high-risk individuals like those with Down syndrome.
Progress
24% Bias Score
Italian Hospital's AI-Powered Screening Improves Rare Disease Diagnosis
The Giovanni XXIII hospital in Bari, Italy, announced that its neonatal screening center identified 31 newborns with rare diseases in 2024, enabling early diagnosis and treatment; since 2017, 492 newborns have been helped through this program, which uses robotic technology and AI to speed up the pro...
Italian Hospital's AI-Powered Screening Improves Rare Disease Diagnosis
The Giovanni XXIII hospital in Bari, Italy, announced that its neonatal screening center identified 31 newborns with rare diseases in 2024, enabling early diagnosis and treatment; since 2017, 492 newborns have been helped through this program, which uses robotic technology and AI to speed up the pro...
Progress
32% Bias Score
Pilot Prostate Cancer Screening Program Launched in Southern Italy
Puglia, Italy, launches a pilot prostate cancer screening program in Foggia province, targeting 100,000 men aged 50-70 to assess the impact on mortality and metastasis rates, collaborating with regional health authorities and the Policlinico Riuniti hospital.
Pilot Prostate Cancer Screening Program Launched in Southern Italy
Puglia, Italy, launches a pilot prostate cancer screening program in Foggia province, targeting 100,000 men aged 50-70 to assess the impact on mortality and metastasis rates, collaborating with regional health authorities and the Policlinico Riuniti hospital.
Progress
44% Bias Score
Showing 25 to 36 of 45 results